CHMA Gross Margin

The Gross Margin of Chiasma Inc (CHMA) is 94.59%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

CHMA Gross Margin - Historical Value

Date	Value
2020-12-31	94.59%

CHMA Gross Margin - Peers Comparison

Ticker	Name	Value
EBM.V	Eastwood Bio-Medical Canada Inc	64.72%
LLY	Eli Lilly and Co	81.31%
PRPH	Prophase Labs Inc	-2.22%
SCPH	scPharmaceuticals Inc	68.73%
SOL.CN	SOL Global Investments Corp	96.92%
ELAN	Elanco Animal Health Inc	54.88%
ETON	Eton Pharmaceuticals Inc	60.01%
VTRS	Viatris Inc	41.65%
XPHY.CN	Xphyto Therapeutics Corp	69.63%
MDWD	Mediwound Ltd	13.03%
PCLO.V	Pharmacielo Ltd	-122.10%
ROMJ.V	Rubicon Organics Inc	58.38%
SBBP	Strongbridge Biopharma plc	92.81%
BMY	Bristol-Myers Squibb Co	75.26%
CRDL.TO	Cardiol Therapeutics Inc	100.00%
NOVN	Novan Inc	68.84%
RPRX	Royalty Pharma PLC	7775.20%
BRCK.U.CN	BellRock Brands Inc	40.84%
CTLT	Catalent Inc	21.75%
INLB	Item 9 Labs Corp	33.61%
MRK	Merck & Co Inc	80.85%
NGW.CN	Next Green Wave Holdings Inc	48.77%
ONTX	Onconova Therapeutics Inc	7775.20%
PFE	Pfizer Inc	74.19%
SCYX	SCYNEXIS Inc	100.00%
ZTS	Zoetis Inc	70.68%
ACRX	AcelRx Pharmaceuticals Inc	-46.33%
ATXI	Avenue Therapeutics Inc	7775.20%
EVFM	Evofem Biosciences Inc	80.20%
EYEN	Eyenovia Inc	-6749.02%
JNJ	Johnson & Johnson	69.11%
SLNG.CN	Slang Worldwide Inc	52.18%
JAGX	Jaguar Health Inc	83.27%
PCSA	Processa Pharmaceuticals Inc	100.00%